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Two assays are described that are suitable for the screening of large numbers  of hybridoma 
supernatants as well as for the screening of a wide range of tissues for the distribution of a given cell 
surface antigen. These assays use whole live cells as targets, avoiding fixation or extraction, which could 
alter the antigenic structural profile. The assays are rapid, simple and inexpensive. Their advantages and 
applications are discussed. 
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Introduction 
The attempt to raise monoclonal antibodies (MoAb) to cell surface antigens has 
created a unique screening problem. Many researchers screen hybridoma super- 
natants against cell extracts or fixed cells. One cannot, however, overlook the risk 
that extraction or fixation procedures expose intra-cellular antigens or, more seri- 
ously, alter the structural configuration of the membrane antigens. It is possible that 
MoAb raised to the in vivo configuration on whole live cells may fail to recognize 
the altered one in vitro screening. 
In an attempt to circumvent this potential problem we have developed 2 related 
screening assays that use whole live cells as targets, thereby obviating concern about 
preservation of the antigenic profile. We have also made these assays sparing of cells, 
using as few as 3000 cells/supernatant screened; particularly useful when the desired 
target cells are scarce or difficult to obtain. In both assays small drops of a target 
cell suspension are applied to nitrocellulose filters in a manner similar to that used 
by Hawkes et al. (1982). These filters then serve as carriers for either an ELISA or a 
Abbreviations: ELISA, enzyme-linked immunosorbent  assay; RIA, radioimmunoassay; BSA, bovine 
serum albumin; PBS, phosphate-buffered saline, pH 7.2; SPA, staphylococcal protein A. 
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RIA. The use of 96-well filtration plates that fit on a vacuum holder (both by 
Millipore Corp.) permits us to perform all washes by suction, considerably reducing 
the amount of time required for each assay. We find these assays to be rapid, 
versatile, and yielding results in excellent agreement with those of a tube-based assay 
long in use in our lab. 
Materials and Methods 
Nitrocellulose or fluorocarbon 96-well filtration plates (Millipore Corp.) with 0.22 
/~m poresize are soaked 1-12 h in phosphate-buffered saline (PBS) containing 1% 
BSA (pH 7), 0.1% polyoxyethylene sorbitan monolaurate (Tween-20; Sigma Chemi- 
cal) to block non-specific binding sites. Excess detergent is removed by repeated 
washings with PBS containing 1% BSA (PBS/BSA). Target cells are washed in 
PBS/BSA, pelleted, and resuspended at the desired concentration; 3000-50,000 
cells//~l will give satisfactory results. Using the vacuum holder (Millipore Corp.), 
mild suction is applied to the plate while 1/~1 of the cell suspension is dotted into the 
center of each well. The mild suction prevents the cell suspension from spreading 
out, but harsh suction should be avoided at all times. 
After a single wash with PBS/BSA the plate is lightly blotted on the bottom to 
prevent seepage of reagents through the filter membrane by capillary action. 
Hybridoma supernatants are added (50 /~l/well is sufficient), and the plate is 
incubated. All incubations are for 30-60 min at 25 ° C, the supernatants are removed 
by suction, the plate is washed 3 times with PBS/BSA, and is lightly blotted before 
addition of the second antibody. The second antibody used depends on the way the 
assay is to be completed (i.e., d-ELISA or d-RIA). 
d-ELISA 
The avidin-biotin-peroxidase complex method (Vectastain ABC kit, Vector 
Laboratories) as described by Hsu et al. (1981) is used. All reagents are diluted in 
PBS/BSA. A biotinylated anti-mouse antibody is applied and allowed to incubate. 
Following 3 washes with PBS/BSA, the avidin-peroxidase complex (ABC) is added 
and the plate is incubated. After a final set of 3 washes with PBS/BSA the developer 
is prepared as follows: 4-chloro-l-naphthol is dissolved in methanol (3 mg/ml) .  
While this solution can be kept in the cold in the dark for approximately 2 weeks, it 
should be discarded when it begins to turn yellow. Shortly before use 5 vols. of PBS 
are added and this solution is brought to 0.01% v / v  H202. This developer is applied 
to the plate (50-75 /zl/well) and allowed tO incubate long enough for the chromo- 
genic reaction to be complete (5-15 min). A positive reaction will give a dark purple 
dot. The plate is washed once with distilled water and allowed to dry. The color of 
positive reactions will fade over time. This process can be slowed considerably by 
keeping the plates in the dark; for permanent records we suggest photographing the 
results within a month of the assay's completion. 
d-RIA 
A polyclonal anti-mouse antibody is applied and allowed to incubate. After the 
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incubation the plate is washed 3 times with PBS only (pH 8) and L~I-labeled 
staphylococcal protein A (SPA) is added (100,000 cpm in 50 /~l/well). BSA is 
eliminated from this and subsequent washes to prevent foam from forming and 
possibly spreading across the bot tom of the plate during the suction washes. Such 
spreading foam, of no concern in the d-ELISA, could carry radioactivity with it, 
which would cause non-specific contamination. The pH of the wash buffer is chosen 
because SPA binds better to IgG1 at pH 8 than at pH 7 (Ey et al., 1978). For this 
same reason the proper dilution of SPA should be made up in PBS at pH 8. 
Following the incubation and a final set of 3 washes with PBS alone (pH 8), the 
plate is allowed to dry, the edges of the plate are broken off to allow close plate-film 
contact, and the plate is placed in a film cassette on XAR film (Kodak) with an 
underlying calcium tungstate intensifying screen (DuPont). Exposure time is 2-12 h 
at - 7 0  o C. Alternatively, single emulsion X-ray film may be used and the exposure 
time lengthened to 10-24 h. 
Tube-based assay (Shaw et aL, 1980) 
Five milliliter polystyrene tubes are filled with PBS/BSA and are allowed to sit 
for 20 min to block non-specific binding sites. The buffer is then poured out and the 
last drops are aspirated. Target cells are washed in PBS/BSA (pH 7), pelleted and 
resuspended at a concentration of 10,000 cells//~l. Fifty microliters of this suspen- 
sion are added to each of the tubes with the exception of the first one, which receives 
50/~1 buffer instead. This blank will eventually provide a measure of the background 
counts. Hybr idoma supernatants are added (50/~l/tube),  the tubes are gently shaken 
and incubated in a shakerbath at 37 o C for 1 h. Upon removal from the shakerbath 
3 ml PBS/BSA (pH 8) are added, the tubes are gently shaken and centrifuged at 
800 x g for 10 min. The supernatant is aspirated carefully without disturbing the 
pellet. 125I-labeled SPA is added (100 ng / t ube  in 250/~1 PBS/BSA (pH 8)), the cells 
are resuspended and incubated on a shaker at 25 o C for 1 h. 
During this incubation 400 btl soft conical polyvinyl chloride centrifuge tubes 
(West Coast Scientific) are filled with PBS/BSA and allowed to sit 20 min to block 
non-specific binding sites. The buffer is aspirated and 200/xl of a Percoll (Pharmacia) 
solution is added, taking care to avoid all bubbles. The desired concentration of 
Percoll varies with cell size, larger cells requiring lower concentrations. For small cell 
carcinoma of the lung cells we have used 15% Percoll in normal saline (v/v) .  
The SPA-reacted cells are triturated briefly and 100 ttl aliquots of each cell 
suspension are carefully layered onto the surface of 2 Percoll tubes. The tubes are 
centrifuged at 10,000 × g for 4 min; this centrifugation pellets the cells while the free 
125I-SPA remains above. The tips of the tubes are cut off above the pellet, and the 
cell-associated 12SI-SPA is counted in a gamma counter. 
Results 
The assays described above are versatile and can be used not only to screen 
hybridoma supernatants for the presence of MoAb, but also to determine tissue 
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distribution of the antigen against which the MoAb was raised. We give examples of 
both types of assays. 
We generated and maintained hybridoma cultures by the usual methods (K6hler 
and Milstein, 1975), using intact cells from a variety of tumors as immunogens. The 
supernatants from these cultures were screened for the presence of specific antibody 
using either the d-ELISA or the d-RIA and comparing the results with those 
obtained by the tube-based assay. 
Agreement between d-ELISA and the tube-based assay was 85% (263/336 
samples), while agreement between d-RIA and the tube-based assay reached 92% 
(260/282 samples). In both assays the 'false negatives' (i.e., a positive result with the 
tube-based assay but a negative result with either of the dot-based assays) were rare, 
constituting approximately 4% of the samples (15/336 for d-ELISA, 12/282 for 
d-RIA). 'False positives' (i.e., a negative result with the tube-based assay but a 
positive result with either of the dot-based assays) were more common with d-ELISA 
than with d-RIA (10% and 6% respectively). A typical d-ELISA screening super- 
natants is shown in Fig. 1. 
The tissue distribution of several antigens against which we have produced MoAb 
is shown in Fig. 2. This assay does not test a range of antibodies against a single 
antigen; instead it employs a range of antigens, in this case single cell suspensions of 
Fig. 1. A d-ELISA assay screening hybridoma supernatants against a single cell type (50,000 cells/well). 
Dark dots show positive reactions. Row A contains no cells, row G contains cells but received no 
antibody (negative controls). B1 and B9 received 1:10 dilutions of 2 different sera, the stained 
background is typical of such high protein concentrations. We recommend diluting sera at least 1 : 100. 
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Fig. 2. A d-RIA assay screening 2 sera, 1 ascites, 1 purified antibody and 2 hybridoma supernatants 
against 5 cell types. Row A: no cells (negative controls). Rows B and C: a choriocarcinoma cell line at 
5000 and 50,000 cells/well respectively. Rows D and E: a small cell lung carcinoma cell line at 5000 and 
50,000 cells/well respectively. Row F: ovarian carcinoma cells from a biopsy, 5000 cells/well. Row G: 
mononuclear cells from peripheral blood, 50,000 cells/well. Row H: melanoma cells from a resected 
tumor, 50,000 cells/well. 
Columns 1, 2, 3: normal mouse serum diluted 1:10, 1:100, and 1:1000 respectively. Columns 4, 5, 6: 
anti-choriocarcinoma antibody diluted 1 : 10, 1 : 100 and 1 : 1000 respectively. Columns 7, 8 :2  undiluted 
hybridoma supernatants. Column 9: undiluted ascites. Column 10: serum of mouse immunized against 
ovarian carcinoma, diluted 1 : 10. 
s eve r a l  n o r m a l  a n d  n e o p l a s t i c  h u m a n  o r g a n s ,  a g a i n s t  w h i c h  a few a n t i b o d i e s  a re  
t e s t ed .  N o t e  t h a t  n o r m a l  m o u s e  s e r u m  fai ls  to  r e a c t  w i t h  cel ls  a l t h o u g h  s o m e  
b a c k g r o u n d  b i n d i n g  is p r e s e n t .  I n  c o n t r a s t ,  t h e  s e r u m  of  t he  i m m u n i z e d  m o u s e  d o e s  
r e a c t  w i t h  cel ls  as  i n d i c a t e d  b y  t he  d a r k e r  d o t  in  t he  m i d s t  o f  b a c k g r o u n d  b i n d i n g .  
C a r e  is t a k e n  to  k e e p  the  f i l ters  a n d  cells  m o i s t  a t  all  t imes .  U n d e r  s u c h  
c o n d i t i o n s  i m m o b i l i z a t i o n  of  cel ls  in  d o t s  d e c r e a s e s  cel l  v i a b i l i t y  o n l y  s l igh t ly  (as  
d e t e r m i n e d  b y  t r y p a n  b l u e  exc lus ion ) .  
Discussion 
W e  h a v e  d e s c r i b e d  2 a s s a y s  t h a t  a re  s u i t a b l e  for  t he  s c r e e n i n g  o f  l a rge  n u m b e r s  o f  
h y b r i d o m a  s u p e r n a t a n t s  fo r  a n t i b o d y  r e a c t i v i t y  w i t h  cel l  s u r f a c e  a n t i g e n s  as wel l  as  
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for the screening of a wide range of tissues for the distribution of a given cell surface 
antigen. Comparisons of these methods with our standard tube-based 125I-SPA/Per- 
coll assay have shown that the 3 assays are of comparable sensitivity and specificity. 
Discrepancies, where they exist, are far more likely to consist of a positive reaction 
with the dot-based assays and a negative reaction with the 125I-SPA/Percoll assay 
( 'false positive'), than the reverse. Some of these 'false positives' are due to the 
presence of IgM and possibly some IgG1, which the tube-based assay does not 
detect. Endogenous peroxidase activity of the target cells may be responsible for the 
higher proportion of 'false positives' with d-ELISA than with d-RIA. The rate of 
'false negatives' is on the order of 4%. Since, in addition, the d-ELISA is not 
quantitative, we use it for rapid initial screening of the supernatants. Only the 
supernatants giving a positive d-ELISA result are tested with the tube-based assay. 
By this process all negative clones, with the exception of 'false negatives', are 
eliminated and all positive ones are quantitated. 
Quantitation can also be performed by means of the d-RIA. Using a filter punch 
(Millipore Corp.), well bottoms (filters) can be punched out and counted in a gamma 
counter. For each sample tested in this manner the amount of background binding 
should be determined by applying supernatant to a well lacking cells. High protein 
concentrations can yield high backgrounds, for this reason sera should be diluted 
before testing. 
The special feature of all 3 assays is the use of whole live cells as targets. Since 
fixation can and does alter some antigens (Baron et al., 1977), there is always the 
possibility that a MoAb raised to the in vivo configuration of a cell surface antigen 
may fail to recognize the potentially altered one on a fixed cell. Availability of cells 
can, however, be a problem and in this respect especially the 1251-SPA/Percoll assay 
suffers from a serious drawback: it requires 200,000-500,000 cel ls /supernatant  
tested. Both dot-based assays can, on the other hand, be performed using as few as 
3000 cells/supernatant  tested, enabling us to use even small biopsies in our 
screening assays. 
Even where unlimited numbers of cells are available, the dot-based assays are 
more suitable for the screening of large numbers of samples since they are consider- 
ably less demanding of time, equipment, and patience than the tube-based assay. We 
find that 4 -5  96-well plates can be screened in < 4 h. Additionally, the d-ELISA 
avoids the use of radioisotopes altogether and is, therefore, particularly desirable for 
the initial screen. Of course, in using the d-ELISA, the usual precautions regarding 
endogenous peroxidase activity of cells should be observed. 
Although the cells need not be applied in a dot (Handley et al., 1982), it should be 
noted that the use of a dot of cells improves the ability to distinguish a positive 
reaction even in the presence of background binding since contrast between dot and 
background aids in detection. 
The use of these assays is not limited to the examples already given. Since purified 
proteins may be dotted onto the filters and used as targets (Hawkes et al, 1982; 
Horejsi and Hilgert, 1983), these assays can also be used to analyze the molecular 
nature of the antigen to which a given MoAb binds, e.g., MoAb reactive with 
neoplastic tissue may be screened against various purified oncofetal proteins. Since 
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such assays do not  require the immobi l iza t ion of whole live cells, however, economy 
may dictate that this assay be carried out on sheets of nitrocellulose filter paper 
rather than in the fil ter-backed plates. 
In summary  the d-ELISA and d-RIA,  which are modif icat ions of a solid-phase 
assay, offer one the abili ty to rapidly and easily screen large numbers  of an t ibody  
samples against whole live cells. In  addit ion,  with equal ease, one type of ant ibody 
may be screened against a number  of tissues. 
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